Rare diseases
Investigational molecules
Locations
Back to Germany36 clinical trials in Buxtehude, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on moderate to severe atopic dermatitis and plaque psoriasis, evaluating novel treatments including amlitelimab, eblasakimab, and ESK-001. Research aims to assess treatment efficacy and long-term safety profiles.
Multiple studies examining maintenance therapy and dose optimization in chronic skin conditions.
Comprehensive studies evaluating advanced melanoma treatments, including adjuvant immunotherapy trials with pembrolizumab and novel combination therapies. Research focuses on both early-stage and metastatic disease.
Emphasis on developing more effective treatment strategies for high-risk melanoma patients.
Investigating treatments for chronic urticaria, hidradenitis suppurativa, and bullous pemphigoid. Studies evaluate innovative therapies including remibrutinib and dupilumab for these challenging conditions.
Focus on improving treatment outcomes for patients with resistant disease forms.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
